A Leader in Medical Cannabis Health Services
Tetra Health provides support to patients and medical
practitioners across Australia via our team of cannabinoid experts.
We Provide Streamlined Access to Safe and Legal Treatment for Patients in Every State and Territory in Australia
3 Simple Steps from Physician Consult to Prescription
STEP 1
Initial Consult
Book a convenient phone consultation with one of our specialist nurses to review your medical history and discuss treatment options. We will develop a personalised care plan that suits your individual needs and treatment goals.
STEP 2
Physician Appointment
Complete your appointment with a physician. We work collaboratively with your treating physicians, and have physicians across Australia to assist as needed, both in clinic and via TeleHealth. We have weekly appointments available with our expert physicians, so you never have to wait.
STEP 3
Approval & Medication
Once TGA and State applications are approved, your prescription is dispensed from a pharmacy. You will receive ongoing treatment support from a specialist nurse as a Tetra Health patient. No lengthy wait times with Tetra – we receive medical cannabis approvals in 24-48 hours!
Are You A Physician Looking For More Information?
Refer your patient to a Tetra Physician with this simple form
Interested In Prescribing Medical Cannabis?
Tetra Health offers CPD Accredited Training and prescribing
assistance for Medical Practitioners and Pharmacists
Our Medical Advisory Board
Prof. Andrew McLachlan
Head of School and Dean of Pharmacy in the Sydney Pharmacy School and a Member of the Order of Australia. He is currently the Program Director of the NHMRC Centre for Research Excellence in Medicines and Ageing.
Dr. Mona Singh
MBBS, MRCGP, FRACGP
Member of CESPHN Clinical Advisory Committee, Medical Editor CESPHN, Medical Officer/Director BUPA, BUPA (BMVS) Education Committee Member
Prof. Stephen Clarke
Medical oncologist, pharmacologist and translational researcher with major clinical and research interests in gastrointestinal and thoracic cancers and pharmacology.
Prof. Philip Morris
Qualified in psychiatry and addiction medicine in Australia. He is Executive Director of the Australian and New Zealand Mental Health Association and Medical Director of the Gold Coast Memory Disorders Clinic.
Prof. Paul Glare
Chair of Pain Medicine in the Northern Clinical School of the University of Sydney and Director of the University’s Pain Management Research Institute (PMRI).
Assoc. Prof. Kellie Charles
Cancer pharmacologist with a research interest in the interactions between inflammation, the immune system and cancer chemotherapy outcomes.
Dr. Samuel Banister
Senior Research Fellow in the School of Chemistry at The University of Sydney. He brings more than 10 years of experience drug discovery and cannabinoid science to the role.
FOLLOW US
© Tetra Health Pty Ltd. All Rights Reserved.